Barrington Research Maintains Outperform on Dentsply Sirona, Lowers Price Target to $13
Benzinga Newsdesk 5 days ago
Analyst RatingsNewsPrice Target
Barrington Research analyst Michael Petusky maintains Dentsply Sirona (NASDAQ:XRAY) with a Outperform and lowers the price target from $15 to $13.
Barrington Research analyst Michael Petusky maintains Dentsply Sirona (NASDAQ:XRAY) with a Outperform and lowers the price target from $15 to $13.